Offered by: Nemours Children's
Location: Orlando, Pensacola en Florida
Characterizing CFTR Modulated Changes in Sweat Chloride (CHEC-SC) and Their Association With Clinical Outcomes
The CHEC-SC study research team is looking at sweat chloride (SC) levels in people with Cystic Fibrosis (CF) who are currently being treated with cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies such as Orkambi, Kayldeco and Symdeko.
Male or female greater than or equal to four months of age on day of study visit that has CF and and is currently being treated with a CFTR modulator therapy for more than three months.
The CHEC-SC study is one (1) study visit.
Pulmonary function test, sweat chloride collection.
Trial Name: Characterizing CFTR Modulated Changes in Sweat Chloride (CHEC-SC) and Their Association With Clinical Outcomes
IRB# 1174204-2
(800) 354-5690 Email UsLearn more about clinical trials and get answers to questions you might have.
Go to FAQs View All Clinical TrialsNemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.